Daiichi, Ranbaxy team to counter FDA charges (rediff.com)
The USFDA has accused Ranbaxy of falsifying data and test results of medicines. A Daiichi Sankyo statement said it takes the issue very seriously. 'Both Daiichi and Ranbaxy have formed a team to solve the issue. Ranbaxy will be responding to the FDA and will continue to cooperate with the agency.' Ranbaxy shares fell more than 18 per cent to Rs 169.85 today on the Bombay Stock Exchange, while ...

FDA Says India's Largest Pharma Company Faked Test Results In Drug Applications (Medical News Today)
The US Food and Drug Administration announced on Wednesday, 25th February, that a plant belonging to India's largest pharmaceutical company, Ranbaxy Laboratories, falsified data and test results in approved and pending applications of generic drugs for the US market.